Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC

Stock Information for Rare Element Resources Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Rare Element Resources Ltd.

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates
Anebulo Pharmaceuticals Announces Final Results of Tender Offer
Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer
Anebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender Offer
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates
Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, under Development for Acute Cannabis-Induced Toxicity
Anebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic Alternatives

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.